NM_022124.6:c.2263C>T

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The filtering allele frequency of the c.2263C>T (p.His755Tyr) variant in CDH23 is 0.73% (248/30558) for South Asian chromosomes by gnomAD v2.1.1, which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen Hearing Loss Expert Panel for autosomal recessive hearing loss variants (BA1). Of note, this variant was reported in 2 individuals with Usher syndrome, though without any evidence of pathogenicity (PM3 not met; PMID:18429043, 21569298). In summary, this variant meets criteria to be classified as benign based on the ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel (BA1). LINK:https://erepo.genome.network/evrepo/ui/classification/CA137317/MONDO:0019497/005

Frequency

Genomes: 𝑓 0.0011 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 13 hom. )

Consequence

CDH23
NM_022124.6 missense

Scores

7
10

Clinical Significance

Benign reviewed by expert panel P:1U:2B:18

Conservation

PhyloP100: 5.96
Variant links:
Genes affected
CDH23 (HGNC:13733): (cadherin related 23) This gene is a member of the cadherin superfamily, whose genes encode calcium dependent cell-cell adhesion glycoproteins. The encoded protein is thought to be involved in stereocilia organization and hair bundle formation. The gene is located in a region containing the human deafness loci DFNB12 and USH1D. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of this cadherin-like gene. Upregulation of this gene may also be associated with breast cancer. Alternative splice variants encoding different isoforms have been described. [provided by RefSeq, May 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDH23NM_022124.6 linkc.2263C>T p.His755Tyr missense_variant Exon 21 of 70 ENST00000224721.12 NP_071407.4 Q9H251-1Q6P152
CDH23NM_001171930.2 linkc.2263C>T p.His755Tyr missense_variant Exon 21 of 32 NP_001165401.1 Q9H251A0A087WYR8Q6P152
CDH23NM_001171931.2 linkc.2263C>T p.His755Tyr missense_variant Exon 21 of 26 NP_001165402.1 Q9H251Q8N5B3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDH23ENST00000224721.12 linkc.2263C>T p.His755Tyr missense_variant Exon 21 of 70 5 NM_022124.6 ENSP00000224721.9 Q9H251-1

Frequencies

GnomAD3 genomes
AF:
0.00109
AC:
166
AN:
152060
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000524
Gnomad ASJ
AF:
0.00865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00892
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000970
Gnomad OTH
AF:
0.00192
GnomAD3 exomes
AF:
0.00218
AC:
542
AN:
248490
Hom.:
1
AF XY:
0.00268
AC XY:
362
AN XY:
134874
show subpopulations
Gnomad AFR exome
AF:
0.000130
Gnomad AMR exome
AF:
0.000696
Gnomad ASJ exome
AF:
0.00657
Gnomad EAS exome
AF:
0.0000557
Gnomad SAS exome
AF:
0.00812
Gnomad FIN exome
AF:
0.000613
Gnomad NFE exome
AF:
0.00156
Gnomad OTH exome
AF:
0.00199
GnomAD4 exome
AF:
0.00145
AC:
2118
AN:
1460878
Hom.:
13
Cov.:
32
AF XY:
0.00171
AC XY:
1246
AN XY:
726652
show subpopulations
Gnomad4 AFR exome
AF:
0.000179
Gnomad4 AMR exome
AF:
0.000828
Gnomad4 ASJ exome
AF:
0.00685
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00856
Gnomad4 FIN exome
AF:
0.000622
Gnomad4 NFE exome
AF:
0.000839
Gnomad4 OTH exome
AF:
0.00212
GnomAD4 genome
AF:
0.00109
AC:
166
AN:
152178
Hom.:
1
Cov.:
32
AF XY:
0.00138
AC XY:
103
AN XY:
74384
show subpopulations
Gnomad4 AFR
AF:
0.000193
Gnomad4 AMR
AF:
0.000523
Gnomad4 ASJ
AF:
0.00865
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00892
Gnomad4 FIN
AF:
0.000471
Gnomad4 NFE
AF:
0.000970
Gnomad4 OTH
AF:
0.00190
Alfa
AF:
0.00142
Hom.:
0
Bravo
AF:
0.000914
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00130
AC:
11
ExAC
AF:
0.00226
AC:
274
Asia WGS
AF:
0.00462
AC:
16
AN:
3478
EpiCase
AF:
0.00256
EpiControl
AF:
0.00237

ClinVar

Significance: Benign
Submissions summary: Pathogenic:1Uncertain:2Benign:18
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Benign:9
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

CDH23: BS1 -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Dec 06, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 30245029, 30718709, 21228398, 18429043, 22135276, 25474345, 22995991, 21569298) -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

May 05, 2022
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

not specified Benign:3
Aug 30, 2016
Eurofins Ntd Llc (ga)
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 15, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: CDH23 c.2263C>T (p.His755Tyr) results in a conservative amino acid change in the encoded protein sequence. Two of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0022 in 248490 control chromosomes, predominantly at a frequency of 0.0081 within the South Asian subpopulation in the gnomAD database, including 1 homozygotes. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 2.5 fold of the estimated maximal expected allele frequency for a pathogenic variant in CDH23 causing Usher Syndrome phenotype (0.0032), strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. To our knowledge, no occurrence of c.2263C>T in individuals affected with Usher Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. Thirteen clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Eight laboratories reported the variant with benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. -

Dec 17, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

p.His755Tyr in exon 21 of CDH23: This variant is not expected to have clinical s ignificance because it has been identified in 0.85% (136/16100) of South Asian c hromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute .org; dbSNP rs181255269). -

Autosomal recessive nonsyndromic hearing loss 12 Uncertain:1Benign:1
Sep 11, 2019
Baylor Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

Jul 01, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Retinitis pigmentosa Pathogenic:1
Apr 01, 2018
Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet
Significance: Likely pathogenic
Review Status: no assertion criteria provided
Collection Method: research

- -

Usher syndrome type 1 Uncertain:1
Apr 15, 2020
Natera, Inc.
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 12;C1832845:Usher syndrome type 1D;C4539685:Pituitary adenoma 5, multiple types Benign:1
Apr 13, 2022
Fulgent Genetics, Fulgent Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Non-Syndromic Hereditary Hearing Impairment Benign:1
-
University of Washington Center for Mendelian Genomics, University of Washington
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: research

- -

Nonsyndromic genetic hearing loss Benign:1
Jan 15, 2020
ClinGen Hearing Loss Variant Curation Expert Panel
Significance: Benign
Review Status: reviewed by expert panel
Collection Method: curation

The filtering allele frequency of the c.2263C>T (p.His755Tyr) variant in CDH23 is 0.73% (248/30558) for South Asian chromosomes by gnomAD v2.1.1, which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen Hearing Loss Expert Panel for autosomal recessive hearing loss variants (BA1). Of note, this variant was reported in 2 individuals with Usher syndrome, though without any evidence of pathogenicity (PM3 not met; PMID: 18429043, 21569298). In summary, this variant meets criteria to be classified as benign based on the ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel (BA1). -

Usher syndrome type 1D Benign:1
May 18, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Retinitis pigmentosa-deafness syndrome Benign:1
Aug 22, 2023
Mendelics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Uncertain
0.0
CADD
Benign
21
DANN
Uncertain
0.98
DEOGEN2
Benign
0.0067
T;T;T;.;T;.
Eigen
Uncertain
0.29
Eigen_PC
Uncertain
0.43
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Uncertain
0.95
D;D;D;D;D;D
M_CAP
Benign
0.0041
T
MetaRNN
Benign
0.0098
T;T;T;T;T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
0.0
.;.;N;.;.;.
PrimateAI
Uncertain
0.63
T
REVEL
Benign
0.21
Sift4G
Benign
0.11
T;T;.;T;T;.
Polyphen
0.95
.;.;P;.;.;.
Vest4
0.64
MVP
0.73
ClinPred
0.048
T
GERP RS
5.5
Varity_R
0.50
gMVP
0.54

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs181255269; hg19: chr10-73453990; API